293 related articles for article (PubMed ID: 16098680)
21. Management of comorbid bipolar disorder and substance abuse.
Vornik LA; Brown ES
J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
[TBL] [Abstract][Full Text] [Related]
22. The relationship between substance abuse and bipolar disorder.
Brady KT; Sonne SC
J Clin Psychiatry; 1995; 56 Suppl 3():19-24. PubMed ID: 7883738
[TBL] [Abstract][Full Text] [Related]
23. Treatment response of bipolar and unipolar alcoholics to an inpatient dual diagnosis program.
Farren CK; Mc Elroy S
J Affect Disord; 2008 Mar; 106(3):265-72. PubMed ID: 17707085
[TBL] [Abstract][Full Text] [Related]
24. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
[TBL] [Abstract][Full Text] [Related]
25. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
26. Substance abuse in bipolar disorder.
Cassidy F; Ahearn EP; Carroll BJ
Bipolar Disord; 2001 Aug; 3(4):181-8. PubMed ID: 11552957
[TBL] [Abstract][Full Text] [Related]
27. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.
Geller B; Cooper TB; Sun K; Zimerman B; Frazier J; Williams M; Heath J
J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):171-8. PubMed ID: 9473913
[TBL] [Abstract][Full Text] [Related]
28. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
29. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G
Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
[TBL] [Abstract][Full Text] [Related]
30. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
[TBL] [Abstract][Full Text] [Related]
31. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.
Strakowski SM; DelBello MP; Fleck DE; Adler CM; Anthenelli RM; Keck PE; Arnold LM; Amicone J
Arch Gen Psychiatry; 2007 Jan; 64(1):57-64. PubMed ID: 17199055
[TBL] [Abstract][Full Text] [Related]
32. Patterns of alcohol consumption in bipolar patients comorbid for alcohol abuse or dependence.
McKowen JW; Frye MA; Altshuler LL; Gitlin MJ
Bipolar Disord; 2005 Aug; 7(4):377-81. PubMed ID: 16026491
[TBL] [Abstract][Full Text] [Related]
33. Inositol augmentation of lithium or valproate for bipolar depression.
Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
Nery FG; Monkul ES; Hatch JP; Fonseca M; Zunta-Soares GB; Frey BN; Bowden CL; Soares JC
Hum Psychopharmacol; 2008 Mar; 23(2):87-94. PubMed ID: 18172906
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
36. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
37. The impact of co-morbid alcohol use disorder in bipolar patients.
Cardoso BM; Kauer Sant'Anna M; Dias VV; Andreazza AC; Ceresér KM; Kapczinski F
Alcohol; 2008 Sep; 42(6):451-7. PubMed ID: 18760714
[TBL] [Abstract][Full Text] [Related]
38. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
[TBL] [Abstract][Full Text] [Related]
39. Naltrexone in patients with bipolar disorder and alcohol dependence.
Brown ES; Beard L; Dobbs L; Rush AJ
Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
[TBL] [Abstract][Full Text] [Related]
40. Comparison between lithium and valproate in the treatment of acute mania.
Shafti SS; Shahveisi B
J Clin Psychopharmacol; 2008 Dec; 28(6):718-20. PubMed ID: 19011453
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
